rom 12:00 p.m.-1:00 p.m. ET, the activity will utilize principles of pharmacology and pharmacodynamics to make individualized treatment decisions to help patients achieve better mental and physical health outcomes.
Rockville, MD July 26, 2007 -- CME Outfitters, LLC, an independent accredited provider of multidisciplinary medical education programming and related healthcare communications services, is pleased to announce an upcoming live and interactive evidence-based neuroscienceCME TV activity titled "Pharmacodynamics of Atypical Antipsychotics: Clinical Correlations and Practice Implications."
Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference, neuroscienceCME TV is a one-hour, live and interactive continuing education (CE) activity where
leading experts discuss clinically relevant, evidence-based issues facing mental health practitioners. Each broadcast's interactivity is enhanced by offering a Q&A segment during
which the faculty presenters can respond to audience comments and questions posed via e-mail, fax, or phone. CME Outfitters has also developed a web-based instant polling feature that
allows live webcast participants a chance to provide real-time input. Online CE credit is offered to participants upon completion of each activity, at neuroscienceCME.com.
Premiering Wednesday, August 22, 2007, from 12:00 p.m.-1:00 p.m. ET, the activity will utilize principles of pharmacology and pharmacodynamics to make individualized treatment decisions
to help patients achieve better mental and physical health outcomes. The recorded satellite broadcast will re-air from 3:00 p.m.-4:00 p.m. ET. This CE activity will also be available as
an archived webcast, podcast, and telephone audioconference shortly after the live broadcast.
There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:
Online: Visit the activity details page at http://www.neuroscienceCME.com/cmea.aspID=241, print and complete the activity details form, and fax to 240.243.1033.
Statement of Need:
Understanding the pharmacodynamic principles of antipsychotic medications can be very helpful in guiding clinicians in certain key aspects of psychopharmacologic practice, including
medication selection, dosing, and management of adverse events. Knowledge of these pharmacodynamic principles is particularly useful in guiding when and how to safely combine or change
antipsychotic medication. Presenting the clinically salient aspects of antipsychotic pharmacodynamics involves understanding the concept of how these agents differentially affect the
dopamine system, and the range of binding actions on other monoamine receptors besides the family of dopamine receptors. Clinicians need to be able to gauge how differences in dopamine
and non-dopamine binding profiles can translate into important clinical effects, including the timing and likelihood of neurologic and other adverse events, interactions with
patient-specific factors such as age, likelihood of withdrawal problems, and other issues related to common practices involving combining psychotropic medications. Understanding the
pharmacology or drug disposition of atypical antipsychotic agents - including their absorption, distribution, metabolism, and elimination - is essential, as these characteristics impact
dosing, drug-drug interactions, withdrawal effects, and eventually the efficacy and safety of these medications. Side effects can complicate and undermine antipsychotic treatment in
various ways by causing or worsening symptoms associated with schizophrenia, including negative, positive, and cognitive symptoms as well as agitation. In this evidence-based
neuroscienceCME TV activity, the experts discuss the clinical correlations and practice implications that can aid clinicians in utilizing basic concepts of pharmacodynamics and
pharmacology to develop individualized treatment strategies to optimize both the mental and physical health of their patients.
Moderator:
Peter Weiden, MD
Director, Psychosis Program
Center for Cognitive Medicine
Department of Psychiatry
University of Illinois at Chicago
Chicago, IL
Faculty:
Christoph U. Correll, MD
Assistant Professor of Psychiatry and Behavioral Sciences
Albert Einstein College of Medicine
Director, Adverse Events Assessment and Prevention Unit
The Zucker Hillside Hospital North Shore
Glen Oaks, NY
Sheldon H. Preskorn, MD
Professor and Chair of Psychiatry and Behavioral Sciences
University of Kansas School of Medicine-Wichita
President and Chief Executive Officer
Clinical Research Institute
Wichita, KS
Learning Objectives:
At the end of this CE activity, participants should be able to:
- Review the basic concepts of pharmacology and pharmacodynamics and their application in clinical practice.
- Recognize the clinical correlation between pharmacodynamic principles and adverse events, withdrawal effects, and drug-drug interactions of atypical antipsychotics.
- Apply principles of pharmacology to individualized treatment decisions to help patients achieve better mental and physical health outcomes.
Target Audience:
Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in
mental health.
Commercial Support:
CME Outfitters, LLC, and CME LLC gratefully acknowledge an educational grant from Bristol-Myers Squibb Company and Otsuka America Pharmaceuticals, Inc., in support of this CE activity.
Credit Information:
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates
this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.
CNE Credit (Nurses):
CME Outfitters, LLC, is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's
Commission on Accreditation.
It has been assigned code 6WASUP-PRV-069. 1.0 contact hours will be awarded upon successful completion. This activity is co-provided with CME LLC.
Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.
CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its
content. (1.0 CE credits)
Note to Addiction Professionals and Professional Counselors: NAADAC and NBCC accept APA and NASW continuing education (CE) credits toward national certification CE requirements. Please
check with your state board to determine which type of CE credit is acceptable toward licensure CE requirements.
NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.
CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number: 376-999-07-011-L01 (live presentation) 376-999-07-011-H01 (recorded programs)
Credit request forms/activity evaluations can be completed online at http://www.cmeoutfitters.com http://www.neuroscienceCME.com and click on "News Room" or visit http://www.neuroscienceCME.com and click on "Subscribe to Clinical Compass."
Contact: Jessica Primanzon
CME Outfitters, LLC
240.243.1308 direct
240.243.1033 fax